SCHEMBL6137425

SCHEMBL6137425

NC1=Nc2cc(-c3ccco3)ccc2C2CCCC12F

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 6/20 0.59
NOS1 P29475 6/20 0.59
NOS2 P35228 6/20 0.59
TAAR1 Q96RJ0 2/20 0.35
SLC6A4 P31645 2/20 0.33
SLC6A3 Q01959 1/20 0.33
HTR2C P28335 1/20 0.32
BACE1 P56817 1/20 0.32
SMARCA2 P51531 1/20 0.32
SMARCA4 P51532 1/20 0.32
PBRM1 Q86U86 1/20 0.32
SRD5A1 P18405 1/20 0.31
TDP2 O95551 2/20 0.31
HRH1 P35367 2/20 0.31
HRH4 Q9H3N8 2/20 0.31
HRH3 Q9Y5N1 2/20 0.31
KCNH2 Q12809 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6137654 0.77 NOS3 (0.68) NOS3NOS1NOS2HTR2C
SCHEMBL6137615 0.77 NOS3 (0.68) NOS3NOS1NOS2HTR2C
SCHEMBL6137311 0.75 NOS1 (1.00) NOS3NOS1NOS2
SCHEMBL6137677 0.74 TDP2 (0.39) NOS3NOS1NOS2SRD5A1TDP2
SCHEMBL6137612 0.73 NOS3 (0.63) NOS3NOS1NOS2
SCHEMBL6643306 0.72 NOS1 (0.56) NOS3NOS1NOS2
SCHEMBL6137722 0.70 NOS3 (0.74) NOS3NOS1NOS2
SCHEMBL6137347 0.70 NOS3 (0.74) NOS3NOS1NOS2
SCHEMBL6137334 0.69 NOS3 (0.72) NOS3NOS1NOS2BACE1
SCHEMBL6137320 0.69 NOS3 (1.00) NOS3NOS1NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1129077-B9 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-07-20 EP disclosed
EP-1129077-B1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-04-20 EP disclosed
US-6579883-B1 Nitrogen monoxide synthases; 4-amino-8-bromo-3a-fluoro-2,3,3a,9b-tetrahydro-1H-cyclopenta (c) quinoline; neurodegenerative, autoimmune, cardiovascular diseases SCHERING AKTIENGESELLSCHAFT (DE) 2003-06-17 US disclosed